Green Square Capital Advisors LLC Pfizer Inc Transaction History

Green Square Capital Advisors LLC

$710 Million
Q3 2024

A detailed history of Green Square Capital Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Green Square Capital Advisors LLC holds 57,467 shares of PFE stock, worth $1.44 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

57,467

Previous 58,654 2.02%

Holding current value

$1.44 Million

Previous $1.64 Million 1.34%

% of portfolio

0.23%

Previous 0.23%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$27.7 - $31.39 $32,879 - $37,259	-1,187 Reduced 2.02%	57,467 $1.66 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $48,751 - $57,128	-1,930 Reduced 3.19%	58,654 $1.64 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $1.18 Million - $1.36 Million	45,604 Added 304.43%	60,584 $1.68 Million
Q4 2023 Jan 18, 2024	SELL	$26.13 - $33.94 $1.2 Million - $1.56 Million	-45,907 Reduced 75.4%	14,980 $431,000
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $145,624 - $170,220	4,538 Added 8.05%	60,887 $2.02 Million
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $329,342 - $381,041	9,118 Added 19.31%	56,349 $2.07 Million
Q1 2023 Apr 14, 2023	BUY	$39.39 - $51.28 $95,126 - $123,841	2,415 Added 5.39%	47,231 $1.93 Million
Q4 2022 Feb 15, 2023	BUY	$41.75 - $54.5 $77,780 - $101,533	1,863 Added 4.34%	44,816 $2.3 Million
Q3 2022 Oct 31, 2022	BUY	$43.76 - $53.42 $98,372 - $120,088	2,248 Added 5.52%	42,953 $1.88 Million
Q2 2022 Jul 20, 2022	BUY	$46.53 - $55.17 $60,349 - $71,555	1,297 Added 3.29%	40,705 $2.13 Million
Q1 2022 May 05, 2022	SELL	$45.75 - $56.69 $471,453 - $584,190	-10,305 Reduced 20.73%	39,408 $2.04 Million
Q4 2021 Mar 08, 2022	SELL	$41.32 - $61.25 $31,775 - $47,101	-769 Reduced 1.52%	49,713 $2.94 Million
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $88,116 - $113,192	2,245 Added 4.65%	50,482 $2.17 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $359,028 - $406,718	9,998 Added 26.15%	48,237 $1.89 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $61,521 - $69,383	1,837 Added 5.05%	38,239 $1.39 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $6,627 - $8,426	198 Added 0.55%	36,402 $1.34 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $36,449 - $42,763	-1,148 Reduced 3.07%	36,204 $1.33 Million
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $154,605 - $187,559	-5,133 Reduced 12.08%	37,352 $1.22 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $21,002 - $30,007	777 Added 1.86%	42,485 $1.39 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $166,443 - $188,892	5,056 Added 13.79%	41,708 $1.63 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $32,262 - $41,835	993 Added 2.78%	36,652 $1.32 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $42,822 - $48,080	1,158 Added 3.36%	35,659 $1.55 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $5.21 Million - $5.73 Million	-138,971 Reduced 80.11%	34,501 $1.47 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $1.29 Million - $1.47 Million	-33,486 Reduced 16.18%	173,472 $7.57 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $708,082 - $858,861	20,542 Added 11.02%	206,958 $9.12 Million
Q2 2018 Aug 20, 2018	BUY	$32.98 - $35.16 $4.52 Million - $4.82 Million	137,026 Added 277.44%	186,416 $6.76 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $50,577 - $58,676	-1,585 Reduced 3.11%	49,390 $1.75 Million
Q4 2017 Feb 22, 2018	SELL	$33.26 - $35.29 $55,843 - $59,251	-1,679 Reduced 3.19%	50,975 $1.85 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $1.33 Million - $1.47 Million	42,914 Added 440.6%	52,654 $1.88 Million
Q2 2017 Aug 14, 2017	BUY	N/A	9,740	9,740 $327,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Green Square Capital Advisors LLC with notifications on news.

Account

Green Square Capital Advisors LLC Pfizer Inc Transaction History